Cindy Leissinger
Professor of Medicine, Pediatrics & Pathology Chief · Tulane University School of Medicine
Credentials: · · · ·
History
- Present
Pediatrics & Pathology Chief Division · Tulane University School of Medicine
- 1975–1979
Research
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
New England Journal of Medicine · 2007 · 1,576 citations
Dose of prophylactic platelet transfusions and prevention of hemorrhage
New England Journal of Medicine · 2010 · 504 citations
Acquired hemophilia A: Updated review of evidence and treatment guidance
Review · American Journal of Hematology · 2017 · 298 citations
- RK
15 papers
- AS
10 papers
- JG
10 papers
- WH
9 papers
8 papers
- LA
8 papers
- MR
8 papers
- BK
7 papers
Grants
- 2002–2013
Hemostasis Clinical Research Network Protocols
National Heart, Lung, and Blood Institute · U01
Contact PI · $2.2M · Tulane University of Louisiana
- 1997–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $89.4K · Tulane University of Louisiana
- 1993–2002
Hemophilia Aids Clinical Trials Initiative-266935162
National Institute of Allergy and Infectious Diseases · N01
Contact PI · $1.3M · National Bleeding Disorders Foundation
- 1992–1997
Retrovirus-Induced Immune Platelet Abnormalities
National Heart, Lung, and Blood Institute · R01
Contact PI · $701.6K · Tulane University of Louisiana
Clinical trials
- 2010
Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
Principal investigator · Completed
Carelon Research
- 2010–2013
Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Principal investigator · Terminated · Phase 3
Carelon Research
- 2009–2010
Principal investigator · Terminated · Phase 3
Carelon Research
- 2008
Principal investigator · Terminated
Carelon Research